Evernorth reaches deals with Novo Nordisk, Eli Lilly to cap GLP-1 copays

The agreements cap monthly out-of-pocket costs for Zepbound and Wegovy at $200 and more deeply discount the drugs for Evernorth’s employer and health plan clients.

Scroll to Top